In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2011 | 25 | Yes |
Popular Name: N-[5-(2-chlorophenyl)-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepin-7-yl]acetamide N-[5-(2-chlorophenyl)-2,10-dihyd…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.35 | 6.07 | -15.91 | 3 | 6 | 0 | 86 | 351.797 | 2 | ↓ |
Lo Low (pH 4.5-6) | 3.35 | 6.25 | -39.49 | 4 | 6 | 1 | 88 | 352.805 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 213 | 0.37 | Binding ≤ 10μM |
CCND1-1-E | G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 352 | 0.36 | Binding ≤ 10μM |
CCNE1-2-E | G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 38 | 0.42 | Binding ≤ 10μM |
CCNE2-2-E | G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 38 | 0.42 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 352 | 0.36 | Binding ≤ 10μM |
CDK2-2-E | Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic | Eukaryotes | 38 | 0.42 | Binding ≤ 10μM |
CDK4-2-E | Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 213 | 0.37 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 726 | 0.34 | Binding ≤ 10μM |
FAK1-1-E | Focal Adhesion Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.38 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 930 | 0.34 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 33 | 0.42 | Binding ≤ 10μM |
Z80427-1-O | RKO (Colon Carcinoma) (cluster #1 Of 1), Other | Other | 793 | 0.34 | Functional ≤ 10μM |
Z80526-1-O | SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other | Other | 700 | 0.34 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 460 | 0.35 | Functional ≤ 10μM |
Z81245-1-O | MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other | Other | 794 | 0.34 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 213 | 0.37 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 352 | 0.36 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 38 | 0.42 | Binding ≤ 1μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 213 | 0.37 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 726 | 0.34 | Binding ≤ 1μM |
FAK1_HUMAN | Q05397 | Focal Adhesion Kinase 1, Human | 180 | 0.38 | Binding ≤ 1μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 352 | 0.36 | Binding ≤ 1μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 38 | 0.42 | Binding ≤ 1μM |
CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 38 | 0.42 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 930 | 0.34 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 33 | 0.42 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 213 | 0.37 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 352 | 0.36 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 38 | 0.42 | Binding ≤ 10μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 213 | 0.37 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 726 | 0.34 | Binding ≤ 10μM |
FAK1_HUMAN | Q05397 | Focal Adhesion Kinase 1, Human | 180 | 0.38 | Binding ≤ 10μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 352 | 0.36 | Binding ≤ 10μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 38 | 0.42 | Binding ≤ 10μM |
CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 38 | 0.42 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 930 | 0.34 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 33 | 0.42 | Binding ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 460 | 0.35 | Functional ≤ 10μM |
Z81245 | Z81245 | MDA-MB-435 (Breast Carcinoma Cells) | 794 | 0.34 | Functional ≤ 10μM |
Z80427 | Z80427 | RKO (Colon Carcinoma) | 793 | 0.34 | Functional ≤ 10μM |
Z80526 | Z80526 | SW480 (Colon Adenocarcinoma Cells) | 700 | 0.34 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the pre-replicative complex | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
Apoptotic cleavage of cellular proteins | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DCC mediated attractive signaling | |
Depolymerisation of the Nuclear Lamina | |
DNA Damage/Telomere Stress Induced Senescence | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
GAB1 signalosome | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
NCAM signaling for neurite out-growth | |
Netrin mediated repulsion signals | |
Neurophilin interactions with VEGF and VEGFR | |
Nuclear Pore Complex (NPC) Disassembly | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p130Cas linkage to MAPK signaling for integrins | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
Pre-NOTCH Transcription and Translation | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
RMTs methylate histone arginines | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal regulatory protein (SIRP) family interactions | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Transcriptional regulation of white adipocyte differentiation | |
Ubiquitin-dependent degradation of Cyclin D1 | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.